No Detail Found!

Cantharidic acid inhibits the malignant progression of colorectal cancer by inhibiting aerobic glycolysis and regulating the PI3K/Akt/P53 pathway

Author(s)
Yan Wei College of Basic Medicine, Nanyang Medicial College,Nanyang, Henan Province,China
Shulin Dai College of Basic Medicine, Nanyang Medicial College,Nanyang, Henan Province,China
Dongyun Zhang College of Basic Medicine, Nanyang Medicial College,Nanyang, Henan Province,China
Ting Zhang College of Basic Medicine, Nanyang Medicial College,Nanyang, Henan Province,China
Xiaoyu Wang College of Pharmacy, Nanyang Medicial College,Nanyang, Henan Province,China
Bolin Liu College of Life Science, Nanyang Normal University,Nanyang, Henan Province,China
Wei Huang College of Traditional Chinese Medicine, Nanyang Medicial College,Nanyang, Henan Province,China
Yin Li The First Affiliated Hospital, Nanyang Medicial College,Nanyang, Henan Province,China
Mingliao Niu Anorectal Zone II, Henan Provincial Hospital of Traditional Chinese Medicine (The Second Affiliated Hospital of Henan University of Chinese Medicine),Zhengzhou, Henan Province,China
Abstract
Cantharidic acid (CA) has shown effective anticancer activity against many solid tumor cells, but it has not been reported in colorectal cancer (CRC). The PFKFB3 overexpression vector was transfected into SW480 and HT29 cells and the cells were treated with CA and PI3K activator 740 Y-P for 24 h. The malignant progression of the cells was evaluated through CCK-8, EdU, Transwell, flow cytometry, LDH release assay and Hoechst 33258 fluorescence. The expressions of aerobic glycolysis (AEG) and PI3K/Akt/P53 pathway were detected using the kit, extracellular acidification rate (ECAR) assay and Western blot. The subcutaneous tumor model was established by subcutaneous injection of SW480 cells. CA could significantly reduce the proliferation, migration and invasion of SW480 and HT29 cells and promote apoptosis and trigger cell cycle arrest. CA could reduce glucose uptake, lactic acid production and glycolytic capacity, reduce p-PI3K and p-Akt protein levels, raise P53 protein level. PFKFB3 overexpressed promoted CRC malignant progression. 740 Y-P could increase the AEG of CRC cells. Finally, CA reduced the volume and weight of CRC xenografts in mice and inhibited AEG and malignant biological behavior. In conclusion, CA inhibited AEG and malignant progression of CRC cells by regulating the PI3K/Akt/P53 pathway.
Publication Details
Page(s) 1632-1646
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 5, Year: 2025

Request the full text from PASTIC

Keywords
colorectal cancer, Aerobic glycolysis, PI3K/Akt/P53 pathway, Cantharidic acid
References
Abedizadeh R,Majidi F,Khorasani HR,Abedi H,Sabour D H .2024 .Colorectal cancer: A comprehensive review of carcinogenesis, diagnosis and novel strategies for classified treatments. Cancer Metastasis Rev., 43(2) : 729-753.
Ancey PB,Contat C,Meylan E .2018 .Glucose transporters in cancer - from tumor cells to the tumor microenvironment. Febs. J., 285(16) : 2926-2943.
Bausys A,Kryzauskas M,Abeciunas V,Degutyte AE,Bausys R,Strupas K,Poskus T .2022 .Prehabilitation in modern colorectal cancer surgery: A comprehensive review. Cancers (Basel), 14(20) : 5017.
Chen YC,Chen PN,Lin CW,Yang WE,Ho YT,Yang SF,Chuang CY .2020 .Cantharidic acid induces apoptosis in human nasopharyngeal carcinoma cells through p38-mediated upregulation of caspase activation. Environ. Toxicol., 35(5) : 619-627.
Feng IC,Hsieh MJ,Chen PN,Hsieh YH,Ho HY,Yang SF,Yeh CB .2018 .Cantharidic acid induces apoptosis through the p38 MAPK signaling pathway in human hepatocellular carcinoma. Environ. Toxicol., 33(3) : 261-268.
Fukushi A,Kim HD,Chang YC,Kim CH .2022 .Revisited metabolic control and reprogramming cancers by means of the warburg effect in tumor cells. Int. J. Mol. Sci, 23(17) : 10037.
Glaviano A,Foo ASC,Lam HY,Yap KCH,Jacot W,Jones RH,Eng H,Nair MG,Makvandi P,Geoerger B,Kulke MH,Baird RD,Prabhu JS,Carbone D,Pecoraro C,Teh DBL,Sethi G,Cavalieri V,Lin KH,Javidi-Sharifi NR,Toska E,Davids MS,Brown JR,Diana P,Stebbing J,Fruman DA,Kumar AP .2023 .PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Mol. Cancer, 22(1) : 138.
Guan HM,Li WQ,Liu J,Zhou JY .2022 .LncRNA HIF1A-AS2 modulated by HPV16 E6 regulates apoptosis of cervical cancer cells via P53/caspase9/ caspase3 axis. Cell Signal, 97 : 110390.
Guan Y,Yao W,Yu H,Feng Y,Zhao Y,Zhan X,Wang Y .2023 .Chronic stress promotes colorectal cancer progression by enhancing glycolysis through β2- AR/CREB1 signal pathway. Int. J. Biol. Sci., 19(7) : 2006-2019.
Hou Y,Zhang X,Yao H,Hou L,Zhang Q,Tao E,Zhu X,Jiang S,Ren Y,Hong X,Lu S,Leng X,Xie Y,Gao Y,Liang Y,Zhong T,Long B,Fang JY,Meng X .2023 .METTL14 modulates glycolysis to inhibit colorectal tumorigenesis in p53-wild-type cells. EMBO Rep, 24(4) : e56325.
Huang Q,Chen L,Yang L,Xie X,Gan L,Cleveland JL,Chen J .2018 .MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis. Proc. Natl. Acad. Sci, 115(15) : E3368-e3377.
Icard P,Shulman S,Farhat D,Steyaert JM,Alifano M,Lincet H M .2018 .How the Warburg effect supports aggressiveness and drug resistance of cancer cells? Drug Resist. , 38 : 1-11.
Katagiri M,Karasawa H,Takagi K,Nakayama S,Yabuuchi S,Fujishima F,Naitoh T,Watanabe M,Suzuki T,Unno M,Sasano H M .2017 .Hexokinase 2 in colorectal cancer: A potent prognostic factor associated with glycolysis, proliferation and migration. , 32(4) : 351-360.
Kocianova E,Piatrikova V,Golias T .2022 .Revisiting the Warburg effect with focus on lactate. Cancers (Basel), 14(24) : 6028.
Kotowski K,Rosik J,Machaj F,Supplitt S,Wiczew D,Jabłońska K,Wiechec E,Ghavami S,Dzięgiel P .2021 .Role of PFKFB3 and PFKFB4 in Cancer: Genetic basis, impact on disease development/ progression and potential as therapeutic targets. Cancers (Basel), 13(4) : 909.
Lin J,Xia L,Oyang L,Liang J,Tan S,Wu N,Yi P,Pan Q,Rao S,Han Y,Tang Y,Su M,Luo X,Yang Y,Chen X,Yang L,Zhou Y,Liao Q Y .2022 .The POU2F1- ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity. Oncogene, 41(7) : 1024-1039.
Liu J,Zhang C,Hu W .2015 .Tumor suppressor p53 and its mutants in cancer metabolism. Cancer Lett, 356(2 Pt A) : 197-203.
Liu M,Hu Y,Lu S,Lu M,Li J,Chang H,Jia H,Zhou M,Ren F,Zhong J F .2020 .IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53- dependent mechanisms in colon cancer. Int. J. Biol. Sci., 16(5) : 882-892.
Lou F and Zhang M .2023 .RFC2 promotes aerobic glycolysis and progression of colorectal cancer. BMC Gastroenterol, 23(1) : 353.
Pu H,Qian Q,Wang F,Gong M,Ge X .2021 .Schizandrin A induces the apoptosis and suppresses the proliferation, invasion and migration of gastric cancer cells by activating endoplasmic reticulum stress. Mol. Med, 24(5) : 787.
Qin R,Fan X,Huang Y,Chen S,Ding R,Yao Y,Wu R,Duan Y,Li X,Khan HU,Hu J,Wang H J .2024 .Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance. Transl. Oncol., 50 : 102156.
Rashidbaghan A,Mostafaie A,Yazdani Y,Mansouri K Y .2020 .(Noisy-le-. grand), 66(6) : 121-126.
Shi L,Pan H,Liu Z,Xie J,Han W .2017 .Roles of PFKFB3 in cancer. Signal Transduct. Target. Ther., 2 : 17044.
Su D .2022 .MCM7 affects the cisplatin resistance of liver cancer cells and the development of liver cancer by regulating the PI3K/Akt signaling pathway. Immunopharmacol, 44(1) : 17-27.
Sun Y,Zhang H,Meng J,Guo F,Ren D,Wu H,Jin X H .2022 .S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway. Cell Rep, 40(7) : 111194.
Michelakis Sutendra G,ED Sutendra G .2013 .Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front. Oncol., 3 : 38.
Wang Q,Wang B,Zhang W,Zhang T,Liu Q,Jiao X,Ye J,Hao Y,Gao Q,Ma G,Hao C,Cui B C .2024 .APLN promotes the proliferation, migration and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway. , 755 : 109983.
Wang S,Cheng Z,Cui Y,Xu S,Luan Q,Jing S,Du B,Li X,Li Y .2023 .PTPRH promotes the progression of non-small cell lung cancer via glycolysis mediated by the PI3K/AKT/mTOR signaling pathway. J. Transl. Med, 21(1) : 819.
Wang SC,Chow JM,Chien MH,Lin CW,Chen HY,Hsiao PC,Yang SF .2018 .Cantharidic acid induces apoptosis of human leukemic HL-60 cells via c-Jun Nterminal kinase-regulated caspase-8/-9/-3 activation pathway. Environ. Toxicol., 33(4) : 514-522.
Xi Y,Garshott DM,Brownell AL,Yoo GH,Lin HS,Freeburg TL,Yoo NG,Kaufman RJ,Callaghan MU,Fribley AM .2015 .Cantharidins induce ER stress and a terminal unfolded protein response in OSCC. J. Dent. Res., 94(2) : 320-329.
Yan J,Gao YM,Deng XL,Wang HS,Shi GT .2023 .Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma. BMC Cancer, 23(1) : 1161.
Yang Z and Liu Z .2020 .The efficacy of (18)F-FDG PET/CT-based diagnostic model in the diagnosis of colorectal cancer regional lymph node metastasis. Saudi. J. Biol. Sci., 27(3) : 805-811.
Zhan L,Su F,Li Q,Wen Y,Wei F,He Z,Chen X,Yin X,Wang J,Cai Y,Gong Y,Chen Y,Ma X,Zeng J .2023 .Phytochemicals targeting glycolysis in colorectal cancer therapy: Effects and mechanisms of action. , 14 : 1257450.
Zhang S,Yang Y,Hua Y,Hu C,Zhong Y C .2020 .NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling. Mol. Med, 22(2) : 774-782.
Zhang Y,Yang X,Ge X,Zhang F X .2019 .Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid hemorrhage mice. Biomed, 109 : 726-733.
Zheng Q,Jing S,Hu L,Meng X .2024 .Evodiamine inhibits colorectal cancer growth via RTKs mediated PI3K/AKT/p53 signaling pathway. J. Cancer, 15(8) : 2361-2372.
0

Citations

0

Downloads

92

Views